A phase II study on TS-1 treatment for aged patients (greater than or equal to 75 years old) with advanced and/or recurrent gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by UMIN.
- 07 Apr 2011 Planned end date changed from 1 Aug 2008 to 1 Jun 2010 as reported by University Hospital Medical Information Network - Japan.
- 07 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.